Advancing the world of health™
Discover the latest innovations in advanced hemodynamic monitoring
Edwards Lifesciences' hemodynamic monitoring products are now part of BD. Meet us in our new location to view and experience live demonstrations of HemoSphere AltaTM Monitor.
Sunrise Session
Tuesday, May 20th
7:00 AM - 8:30 AM
Two Sides of the Heart: Don’t Let the Right Ventricle Get Left Behind
Join us to explore the latest technologies to detect and monitor hemodynamic instability in critically-ill patients. Our speakers will discuss their experiences with advanced monitoring technologies throughout the spectrum of patient complexity in critical care, including methods to directly monitor and use right ventricular (RV) pressure to assess for RV dysfunction and failure, which is common in the ICU. Finally, use your clinical decision-making skills to navigate an interactive case study.
Objectives:
- Explore the latest advanced hemodynamic monitoring technologies, including appropriate application based on individualized patient need
- Understand the RV’s role in maintaining hemodynamic stability in a variety of clinical situations, including when and how to assess it
Presenters:
Alan C. Heffner, MD
Co-Director of Critical Care
ECMO Medical Director
Pulmonary and Critical Care Consultants
Department of Internal Medicine
Department of Emergency Medicine
Carolinas Medical Center
UNC School of Medicine - Charlotte Campus
Barbara McLean, MN, RN, CCNS-BS, NP-BC, CCRN, FCCM
Critical Care Clinical Nurse Specialist
Critical Care Program Specialist
Grady Health System
Register for our Sunrise Session through the AACN app.
Unable to pre-register? Limited walk-ins will be allowed on a space-available basis.
Join ExpoEd sessions at the BD booth - Gain deeper hemodynamic insights
Functional Hemodynamics: Turning Advanced Concepts into Bedside Tools
Kathy Crawford, MSN, RN, CCRN
Tuesday, May 20 at 12:00 PM
Wednesday, May 21 at 12:00 PM
Hemodynamic instability presents a common and complex issue in the ICU. Join Kathy as she unpacks the fundamental concepts of assessing hemodynamic instability and practical application of these concepts at the bedside. Using multiple real-world case studies, Kathy will show how advanced hemodynamic monitoring can support your clinical assessment, decision making, and communication with colleagues when caring for critically-ill patients.
Turning Right: The Right Ventricular Response in Critical Illness
Barbara McLean, MN, RN, CCNS-BC, NP-BC, CCRN, FCCM
Tuesday, May 20 at 10:30 AM
Wednesday, May 21 at 2:15 PM
The role of the right ventricle in acute hypoxic states is becoming increasingly important in the ICU. RV dysfunction, a common cause of death in the ICU, is often overlooked or misunderstood. Discover how information from the pulmonary artery catheter and other bedside tools provides measures of both dysfunction and response to intervention. Apply these concepts towards two patient case studies, using the right ventricular monitoring measures that informed their successful treatment paths.
Implementing Decision-Support Protocols to Manage Hemodynamic Instability in the ICU
Amanda Rea, DNP, CRNP, AGACNP-BC, CCRN, CMC, CSC, E-AEC
Tuesday, May 20 at 2:15 PM
Wednesday, May 21 at 12:45 PM
Advanced hemodynamic monitoring is crucial for understanding physiological changes in critically-ill patients. Join Amanda as she shares how her facility implemented an advanced hemodynamic monitoring decision-support algorithm to improve care and reduce complications of postoperative cardiac surgery patients. See real-world examples of implementing predictive monitoring to help detect hemodynamic instability, assess volume responsiveness, and manage vasoactive drips to improve patient outcomes.
Discover the latest innovations in advanced hemodynamic monitoring
HemoSphere Alta™ Monitor
Purpose-built with smart and predictive parameters, HemoSphere Alta™ Monitor is designed to help you detect hemodynamic instability before it occurs—so you can stay ahead of critical moments. Explore the latest generation of HemoSphere Alta™ Monitor and reimagine the way you see hemodynamic monitoring.
Swan-Ganz IQ™ Catheter
Swan-Ganz IQ™ Catheter advances right heart monitoring with continuous right ventricular cardiac output (CORV), Global Hypoperfusion Index (GHI), Smart Wedge™ and right ventricular pressure (RVP) parameters, all available on HemoSphere Alta™ Monitor.
ForeSight IQ™ Tissue Oximetry Parameters
Now available, Cerebral Autoregulation Index (CAI) Algorithm is intended to represent whether cerebral autoregulation is likely impaired or intact, while continuous total hemoglobin (tHb) algorithm noninvasively monitors systemic hemoglobin.
Unlock with ForeSight IQ™ Tissue Oximetry Sensor.
Meet the unique monitoring needs of your pediatric patients
Discover a comprehensive hemodynamic monitoring portfolio specifically indicated for pediatric patients*, all on a single monitor - with noninvasive, minimally-invasive, and invasive solutions so you can individualize patient management.
*ForeSight Jr™ Sensors may be used on pediatric patients of all ages. ClearSight Jr™ Cuff, FloTrac Jr™ Sensor, and Swan-Ganz Jr™ Catheter are indicated for patients ≥12 years old.
CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
CERP credits provided by AACN. Participant spouses or guests may not attend, and no items or benefits will be provided to them. Speakers, instructors and panel members may receive compensation and reimbursement of reasonable travel expenses from BD for their services in compliance with applicable laws, and the AdvaMed Code of Ethics.
All speakers are paid consultants of BD.
The value of any food or refreshments provided by BD at this meeting will be apportioned among all attendees. If you expressly decline to partake of any offered food or refreshments, or desire to personally pay for such food or refreshments, please let your BD representative know.
BD, the BD logo, Acumen, Acumen IQ, Advancing the world of health, ClearSight, ClearSight Jr, FloTrac, FloTrac Jr, ForeSight, ForeSight IQ, ForeSight Jr, HemoSphere, HemoSphere Alta, HPI, Hypotension Prediction Index, Smart Wedge, Swan, Swan-Ganz , Swan-Ganz IQ and Swan-Ganz Jr are trademarks of Becton, Dickinson and Company. Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.
© 2025 BD. All rights reserved. PP--US-10984 v1.0.